Effects of High-Frequency Oscillatory Ventilation in ICU Patients
Official title: Physiological Effects and Safety of Continuous High-frequency Oscillatory Ventilation in ICU Patients
Run by Shanghai Zhongshan Hospital · NCT06702813 · Data updated 2026-11-12
This study is testing whether a new breathing treatment called Continuous High-Frequency Oscillatory Ventilation can improve lung function and comfort for awake ICU patients with collapsed lungs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Months to 80 Years |
| Sex | All |
| Enrollment | 45 (estimated) |
| Sponsor | Shanghai Zhongshan Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | November 19, 2024 |
| Main results expected | December 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | November 25, 2024 |
| Trial ID | NCT06702813 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are ICU patients aged 18 to 90 with atelectasis who are alert and able to communicate.
✕Probably not a fit
Patients with severe chronic respiratory diseases or significant hemodynamic instability may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates the safety and efficacy of Continuous High-Frequency Oscillatory Ventilation (CHFO) in awake ICU patients suffering from atelectasis. The study aims to assess pulmonary function by comparing chest electrical impedance tomography (EIT) measurements before and after CHFO treatment. A minimum of 45 patients will be enrolled, and their vital signs and subjective comfort ratings will be collected throughout the treatment process. The goal is to determine the impact of CHFO on lung function and patient comfort in a critical care setting.
Why it matters
Potential benefit: If successful, this study could improve lung function and comfort for critically ill patients with atelectasis.
How similar studies have gone: While the use of CHFO has been explored, this specific evaluation in awake critically ill patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients older than 18 and younger than 90 years; * Admitted to the ICU after December 1, 2024, who are alert, with a GCS of 15, normal comprehension, and able to communicate clearly through speech or writing. * Patients with atelectasis, who are receiving oxygen therapy, high-flow oxygen, or are on a ventilator via tracheostomy. * Signed informed consent for MetaNeb treatment. Exclusion Criteria: * Refusal to participate in the proposed study. * Age \< 10 years; * Pregnancy; * Significant hemodynamic instability defined as an increase of more than 20% in catecholamine doses in the last hour, despite optimization of blood volume, for a target mean blood pressure between 65 and 75 mmHg. * Participation in another trial within 30 days prior to meeting eligibility criteria; * Severe chronic respiratory disease requiring long-term oxygen therapy or home mechanical ventilation; * Pneumothorax. With a clear tracheoesophageal fistula
Where it's running
-
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Shengyu Hao, PhD
- Email: janet9yu@163.com
- Phone: 02164041990
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of suctioning on pain and stress in intubated ICU patients
This study is testing if suctioning the breathing tube in ICU patients causes more pain and stress compared to not suctioning.
-
Using High-flow Nasal Oxygen during Intubation in Critically Ill Patients
This study is testing if using High Flow Nasal Oxygen during intubation can help critically ill patients breathe better and avoid problems compared to standard methods.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.